These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15342912)

  • 1. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.
    Aoki M; Jiang H; Vogt PK
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13613-7. PubMed ID: 15342912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.
    Aoki M; Blazek E; Vogt PK
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):136-41. PubMed ID: 11134523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome.
    Plas DR; Thompson CB
    J Biol Chem; 2003 Apr; 278(14):12361-6. PubMed ID: 12517744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.
    Bader AG; Felts KA; Jiang N; Chang HW; Vogt PK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12384-9. PubMed ID: 14530393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.
    Hu MC; Lee DF; Xia W; Golfman LS; Ou-Yang F; Yang JY; Zou Y; Bao S; Hanada N; Saso H; Kobayashi R; Hung MC
    Cell; 2004 Apr; 117(2):225-37. PubMed ID: 15084260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.
    Kim SJ; Winter K; Nian C; Tsuneoka M; Koda Y; McIntosh CH
    J Biol Chem; 2005 Jun; 280(23):22297-307. PubMed ID: 15817464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.
    Bader AG; Vogt PK
    Mol Cell Biol; 2005 Mar; 25(6):2095-106. PubMed ID: 15743808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
    Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt.
    Nakae J; Kitamura T; Ogawa W; Kasuga M; Accili D
    Biochemistry; 2001 Oct; 40(39):11768-76. PubMed ID: 11570877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The akt kinase: molecular determinants of oncogenicity.
    Aoki M; Batista O; Bellacosa A; Tsichlis P; Vogt PK
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14950-5. PubMed ID: 9843996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation.
    Matsuzaki H; Daitoku H; Hatta M; Tanaka K; Fukamizu A
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11285-90. PubMed ID: 13679577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells.
    Jiang BH; Zheng JZ; Aoki M; Vogt PK
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1749-53. PubMed ID: 10677529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
    Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.
    Bai D; Ueno L; Vogt PK
    Int J Cancer; 2009 Dec; 125(12):2863-70. PubMed ID: 19609947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD; Kao MC; Lin JK
    J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
    Valverde AM; Fabregat I; Burks DJ; White MF; Benito M
    Hepatology; 2004 Dec; 40(6):1285-94. PubMed ID: 15565601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4.
    Goruppi S; Kyriakis JM
    J Biol Chem; 2004 May; 279(20):20950-8. PubMed ID: 15016802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.